GPT and tuberculosis: Interestingly, combined treatment with dapagliflozin and silymarin resulted in a notable decrease in serum levels of ALT (30.27 ± 2.29; p < 0.001), AST (100.85 ± 11.09; p < 0.001), AST:ALT ratio (3.34 ± 0.43; p = 0.021), and TB (0.33 ± 0.05; p < 0.001) compared to the CCl4--intoxicated hepatotoxic control group.